Friday, November 30, 2012

Google Alert - pharmaceutical news

News9 new results for pharmaceutical news
 
Maker of Generic Lipitor Halts Production
New York Times
Ranbaxy Pharmaceuticals, the largest producer of the generic version of Lipitor, has halted production of the drug until it can figure out why glass particles may have ended up in pills that were distributed to the public, the Food and Drug ...
See all stories on this topic »
TEVA PHARMACEUTICAL INDUSTRIES LIMITED : Teva Provides 2013 Non ...
4-traders
2013 Non-GAAP Diluted EPS of $4.85 to $5.15. Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) provided its current outlook for non-GAAP financial performance for the full year ending December 31, 2013. Financial Targets: Total net revenues of between ...
See all stories on this topic »
Government has little role in controlling prices of patented drugs
Economic Times
Since inception of NPPA in August 1997, there are 885 cases where demand notices have been issued to pharmaceutical companies amounting to Rs 2,577.28 crore for selling medicines at a price higher than that fixed by NPPA. "Till October 31, 2012, ...
See all stories on this topic »
Perrigo settles generic Ofirmev patent litigation with Cadence Pharma
pharmabiz.com
Perrigo Company, a leading global healthcare supplier that develops, manufactures and distributes OTC and prescription pharmaceuticals, nutritional products, API and consumer products, has agreed to settle its Hatch-Waxman litigation relating to ...
See all stories on this topic »
BIOCRYST PHARMACEUTICALS, INC. : BioCryst Pharmaceuticals and Presidio ...
4-traders
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) and privately held Presidio Pharmaceuticals, Inc. today announced the mutual termination of the Merger Agreement and the related Investor Financing Agreement entered into on October 17, 2012. Although ...
See all stories on this topic »
Dr Abdul Kalam to inaugurate 64th Indian Pharmaceutical Congress in Chennai ...
pharmabiz.com
Former president of India Dr APJ Abdul Kalam will inaugurate the 64th Indian Pharmaceutical Congress (IPC) at SRM University Campus in Chennai on December 6. The inaugural session will be conducted after the valedictory session of the pre-conference ...
See all stories on this topic »
CLSA raises target price of Lupin, Cipla, Sun Pharma
Economic Times
MUMBAI: CLSA has increased target prices of pharmaceutical majors Lupin, Cipla and Sun Pharmaceuticals. The brokerage continues to remain positive on the Indian pharmaceutical companies as it sees strong growth from the US markets and steady ...
See all stories on this topic »
Janssen Alzheimer, Elan Pharmaceuticals and Genomic Health Discuss Clinical ...
Equities.com
Over fifty healthcare industry professionals and Healthcare IT experts attended the fifth session of the Silicon Valley BioTalks, a quarterly panel discussion and networking venue co-sponsored by Clinovo and SNR Denton. The event took place on November ...
See all stories on this topic »
Glenn Saldanha honoured with 'Swiss Ambassador's Award for Exceptional ...
Express Pharma
This award is even more meaningful because it's being presented by a country which is one of the leading innovation research destinations for the pharmaceutical industry, offering the best combination of infrastructure and talent for new drug discovery ...
See all stories on this topic »


Tip: Use site restrict in your query to search within a site (site:nytimes.com or site:.edu). Learn more.

Delete this alert.
Create another alert.
Manage your alerts.

Thursday, November 29, 2012

Google Alert - pharmaceutical news

News9 new results for pharmaceutical news
 
Patents appeal board rejects AstraZeneca's plea on cancer drug
Economic Times
Global pharmaceutical companies have suffered a string of defeats in India, where the law amended in 2005 ensures patent protection for new drug compounds but is loath to recognise new forms of existing medicines. Multinational pharma companies, on ...
See all stories on this topic »

Economic Times
Pharmaceuticals and universities working together on multi million pound project
University of Manchester
The €26.4 (£21.2M) project, CHEM21, brings together six pharmaceutical companies, 13 Universities and four small to medium enterprises from across Europe. The aim is to develop sustainable biological and chemical alternatives to finite materials, such ...
See all stories on this topic »

University of Manchester
TEKMIRA PHARMACEUTICALS CORPORATION : Tekmira Acquires Worldwide ...
4-traders
VANCOUVER, British Columbia, Nov. 29, 2012 (GLOBE NEWSWIRE) -- Tekmira Pharmaceuticals Corporation (Nasdaq:TKMR) (TSX:TKM), a leading developer of RNA interference (RNAi) therapeutics, announced today that it has obtained a worldwide, ...
See all stories on this topic »
Irish Economy: Pharmaceutical patent cliff no growth threat; High exports have ...
FinFacts Ireland
Irish Economy: Given the official mantras on export growth in recent years from ministers, the Department of Finance, the Central Bank of Ireland and the semi-official Economic and Social Research Institute (ESRI), coupled with echoing in Troika ...
See all stories on this topic »

FinFacts Ireland
REXAHN PHARMACEUTICALS, INC. : Rexahn Pharmaceuticals Prices Public ...
4-traders
REXAHN PHARMACEUTICALS, INC. (NYSE MKT: RNN) today announced the pricing of an underwritten public offering of 19,130,435 shares of its common stock and warrants exercisable for up to 10,521,739 additional shares at $0.33 per fixed combination ...
See all stories on this topic »
Cadence Pharmaceutical's Patent Settlement Bolsters My Buy Rating
Seeking Alpha
Cadence Pharmaceuticals (CADX) is up about 6% today on the announcement that it has entered into a settlement with Perrigo (PRGO) on patent litigation regarding Ofirmev is a positive. Uncertainty over the patent situation of Ofirmev has been a dark ...
See all stories on this topic »
Healthcare Review: Arena Pharmaceuticals, Rexahn Pharmaceuticals, Nymox ...
Reuters
Arena Pharmaceuticals, Inc.(ARNA) enters into a co-development and license agreement with Ildong Pharmaceutical for Temanogrel, ARNA's treatment for myocardial infarction, acute coronary syndrome, stroke, peripheral artery disease, and other ...
See all stories on this topic »
NanoPass Technologies Grants a Commercial License to Janssen ...
Sacramento Bee
Yotam Levin, Chief Executive Officer of NanoPass, said, "We are delighted to enter into this license agreement with Janssen, a leading pharmaceutical company. We see a significant opportunity for improving immunogenicity and/or reducing the dose of ...
See all stories on this topic »
Pharmaceutical Marketing Ideas and Strategy from ByReputation's New ...
Equities.com
With the use of organic search engine optimization, local search directories, and content marketing, ByReputation is putting forth a new pharmaceutical marketing service to help patients obtain more services. To get a free pharmaceutical marketing ...
See all stories on this topic »


Tip: Use quotes ("like this") around a set of words in your query to match them exactly. Learn more.

Delete this alert.
Create another alert.
Manage your alerts.

Wednesday, November 28, 2012

Google Alert - pharmaceutical news

News10 new results for pharmaceutical news
 
Valeant Pharmaceuticals Announces New Management Appointments
Sacramento Bee
MONTREAL, Nov. 28, 2012 -- /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) announced today that Ryan Weldon and Jason Hanson will be named to Valeant's Executive Management Team. Mr. Weldon will assume ...
See all stories on this topic »
Cadence Pharmaceuticals Announces Settlement of OFIRMEV ...
Sacramento Bee
SAN DIEGO, Nov. 28, 2012 -- /PRNewswire/ -- Cadence Pharmaceuticals, Inc. (Nasdaq: CADX) today announced that it has entered into settlement and license agreements with Perrigo Company (Nasdaq: PRGO; TASE), and its subsidiary, Paddock ...
See all stories on this topic »
Industrialist Indravadan Ambalal Modi and Founder of Cadila Pharmaceuticals ...
Jagran Josh
Indravadan A. Modi Founder of Cadila Pharmaceuticals and industrialist, Indravadan Ambalal Modi died on 26 November 2012 after suffering from a brief illness and respiratory disorder. The 87 year old industrialist was the Chairman of Cadila ...
See all stories on this topic »

Jagran Josh
Ampio Pharmaceuticals, Inc. (AMPE) announces appointment of Josh Disbrow ...
Sacramento Bee
GREENWOOD VILLAGE, Colo., Nov. 28, 2012 -- /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (AMPE), a biopharmaceutical company developing repurposed drugs and new molecular entities (NMEs) that treat inflammatory diseases, including osteoarthritis, ...
See all stories on this topic »
Par Pharmaceutical Begins Shipment of Generic Symbyax®
The Herald | HeraldOnline.com
28, 2012 /PRNewswire/ -- Par Pharmaceutical Companies, Inc. today announced that its Par Pharmaceutical, Inc. operating subsidiary has received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for ...
See all stories on this topic »
Arena Pharmaceuticals and Ildong Pharmaceutical Enter Into Co-Development ...
Sacramento Bee
SAN DIEGO, Nov. 28, 2012 -- /PRNewswire/ -- Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) today announced that it has entered into a co-development and license agreement with Ildong Pharmaceutical Co., Ltd., for temanogrel, Arena's internally ...
See all stories on this topic »
Andheri East's Pharma SMEs Hail Government Funding
Economic Times
At the recently conducted pharmaceutical event CPhI, secretary of Commerce, SR Rao said that the government will invest $500 million into 8,000 small to medium pharmaceutical manufacturers in India. MUMBAI: At the recently conducted pharmaceutical ...
See all stories on this topic »

Economic Times
REXAHN PHARMACEUTICALS, INC. : Teva Pharmaceutical to Increase ...
4-traders
Rexahn Pharmaceuticals, Inc. (NYSE Amex: RNN), a clinical stage pharmaceutical company commercializing potential best-in-class oncology and central nervous system (CNS) therapeutics, today announced that Teva Pharmaceutical Industries Ltd. (Teva) ...
See all stories on this topic »
Stellar Pharmaceuticals Appoints Chief Scientific Officer to Support Growing ...
Equities.com
Dr. Chiasson was also employed by Bayer Healthcare Canada, a division of Bayer AG, a global pharmaceutical company with over $38 billion in revenues, as Director, Scientific Development Biologic, Products for Canada, as part of the Canada, Japan and ...
See all stories on this topic »
Sagent Pharmaceuticals Announces Launch of Nafcillin for Injection, USP
NASDAQ
SCHAUMBURG, Ill., Nov. 28, 2012 (GLOBE NEWSWIRE) -- Sagent Pharmaceuticals, Inc. (Nasdaq:SGNT) today announced the launch of Nafcillin for Injection, USP, in two vial presentations and one pharmacy bulk package bottle; all three are latex-free and ...
See all stories on this topic »


This once a day Google Alert is brought to you by Google.

Delete this alert.
Create another alert.
Manage your alerts.

Tuesday, November 27, 2012

Google Alert - pharmaceutical news

News10 new results for pharmaceutical news
 
Chairman of Cadila Pharmaceuticals IA Modi passes away
pharmabiz.com
Pioneer of Indian pharmaceuticals industry, Modi is revered in the Indian pharmaceutical Industry as the champion of Indian Patents Act, 1970 which helped the Indian pharmaceuticals industry in attaining its present global status. He played a major ...
See all stories on this topic »

pharmabiz.com
Collegium Pharmaceutical to Present at Piper Jaffray's 24th Annual Healthcare ...
Sacramento Bee
CUMBERLAND, R.I., Nov. 27, 2012 -- /PRNewswire/ -- Collegium Pharmaceutical, Inc., a specialty pharmaceutical company focused on the development of innovative treatments for chronic pain, is pleased to announce it will present at Piper Jaffray's 24th ...
See all stories on this topic »
Unigene and Tarix Pharmaceuticals Enter Definitive Licensing Agreement for ...
Sacramento Bee
According to terms of the licensing agreement, Tarix will have an exclusive worldwide license to Unigene's Peptelligence™ technology covering the use of that technology with Angiotensin (1-7), the pharmaceutical ingredient in TXA127, as well as its ...
See all stories on this topic »
Pharmaceutical industry: some suggestions
DAWN.com
THIS is with reference to the advertisement supplement of Dawn regarding enactment of Drug Regulatory Authority of Pakistan (DRAP) Bill 2012. Nasir M. Shaikh, the Vice-Chairman of the Pakistan Pharmaceutical Merchants Association, has rightly indicated ...
See all stories on this topic »
Pharmaceutical Market Fails to Capture $188B US Revenue and $564B Global ...
Pharmaceutical Processing
Capgemini Consulting has announced the release of its study conducted with HealthPrize Technologies, "Estimated Annual Pharmaceutical Revenue Loss Due to Medication Non-Adherence." The report provides key insights and analysis on the significant ...
See all stories on this topic »
Regulus Appoints Victor Knopov, Ph.D. as Vice President, Pharmaceutical ...
Sacramento Bee
LA JOLLA, Calif., Nov. 27, 2012 -- /PRNewswire/ -- Regulus Therapeutics Inc. (NASDAQ:RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs, announced today the appointment of Victor ...
See all stories on this topic »
Sucampo Pharma, Abbott launch Amitiza in Japan to treat chronic constipation
pharmabiz.com
Sucampo Pharmaceuticals, Inc. (SPI), a global pharmaceutical company, and Abbott have introduced Amitiza (lubiprostone) in Japan, a prescription medicine for the treatment of chronic constipation not caused by organic diseases. Amitiza was approved by ...
See all stories on this topic »
Transcept Pharmaceuticals to Host Conference Call to Discuss Broadened ...
Sacramento Bee
POINT RICHMOND, Calif., Nov. 26, 2012 -- /PRNewswire/ -- Transcept Pharmaceuticals, Inc. (Nasdaq: TSPT), a specialty pharmaceutical company focused on the development and commercialization of proprietary products that address important therapeutic ...
See all stories on this topic »
Govt told SC: Need 2 more weeks to notify drug pricing policy
Business Standard
The Department of Pharmaceuticals (DoP) is likely to notify the National Pharmaceutical Pricing Policy (NPPP) in around two weeks, it informed the Supreme Court (SC) on Tuesday. The apex court, which has been creating pressure on the government to fast ...
See all stories on this topic »
SANTEN PHARMACEUTICAL CO., LTD. : Intravitreal VEGF Inhibitor "EYLEA ...
4-traders
Osaka, November 27, 2012 - Bayer Yakuhin, Ltd. (Osaka, hereafter Bayer Yakuhin) and Santen Pharmaceutical Co., Ltd. (Osaka, hereafter Santen) today launched the intravitreal VEGF* inhibitor "EYLEA® solution for intravitreal injection 40 mg/mL" ...
See all stories on this topic »


This once a day Google Alert is brought to you by Google.

Delete this alert.
Create another alert.
Manage your alerts.

Monday, November 26, 2012

Google Alert - pharmaceutical news

News3 new results for pharmaceutical news
 
Buy MAP Pharmaceutical For 70% Upside
Seeking Alpha
MAP Pharmaceuticals (MAPP) saw an appreciation of 20% on Friday. We believe this is just the start of an epic run for MAPP shareholders. The company's application for LEVADEX was rejected by FDA back in March due to CMC issues and no objections ...
See all stories on this topic »
Barely surviving to thriving - a remarkable 27-year journey with HIV
Canada NewsWire (press release)
After three months the HIV virus could no longer be detected in his system. Tiko now lives an active healthy life, and continues his work as a visual artist in Vancouver. (CNW Group/CANADA'S RESEARCH-BASED PHARMACEUTICAL COMPANIES (RX&D)) ...
See all stories on this topic »

Canada NewsWire (press release)
China Nuokang Bio-Pharmaceutical Inc posts lower net income of CNY2.5m for ...
MENAFN.COM
Nov 26, 2012 (Menafn - M2 EQUITYBITES via COMTEX) --Biopharmaceutical company China Nuokang Bio-Pharmaceutical Inc (nasdaqgm:NKBP) stated on Sunday its net income of CNY2.5m (CNY0.13 per diluted ADS) for the third quarter of 2012.
See all stories on this topic »


Tip: Use a minus sign (-) in front of terms in your query that you want to exclude. Learn more.

Delete this alert.
Create another alert.
Manage your alerts.

Sunday, November 25, 2012

Google Alert - pharmaceutical news

News5 new results for pharmaceutical news
 
New drug policy will hurt investment in pharma sector: Industry
NDTV
New Delhi: Prices of various leading drug brands will come down by up to 80 per cent thanks to the newly-approved National Pharmaceutical Pricing Policy but at the same time it will hurt investment sentiments in the country's pharmaceutical sector, ...
See all stories on this topic »
China Nuokang Bio-Pharmaceutical Inc. Reports Third Quarter 2012 Financial ...
NASDAQ
BEIJING, Nov. 25, 2012 (GLOBE NEWSWIRE) -- China Nuokang Bio-Pharmaceutical Inc. (Nasdaq:NKBP) ("Nuokang" or the "Company"), a leading China-based biopharmaceutical company focused on the research, development, manufacture, marketing and ...
See all stories on this topic »
GoM has resolved all issues on drug pricing policy: Pawar
Hindu Business Line
The Group of Ministers on pharmaceutical pricing policy has resolved all issues, claimed its Chairman Sharad Pawar here on Wednesday. Talking to reporters after a meeting of the GoM, Pawar said the policy would now go the Cabinet for its final approval.
See all stories on this topic »
مندوب تحصيل -Collection Representative
Emirates 24/7
Since establishment in 1996 as an authorized distributor for Saudi Pharmaceutical Industries & Medical Appliances Corporation (SPIMACO), ARAC powerfully penetrated the Kingdom's market of pharmaceuticals and relevant healthcare products distribution.
See all stories on this topic »
Elder Pharma set to enter regulated markets of EU
Hindu Business Line
Elder Pharmaceuticals Ltd has said it is set to enter the regulated markets of European Union following the receipt of Certificate of Suitability (COS) from European Directorate for the Quality of Medicines and Healthcare (EDQM) for Diosmin API.
See all stories on this topic »


Tip: Use a minus sign (-) in front of terms in your query that you want to exclude. Learn more.

Delete this alert.
Create another alert.
Manage your alerts.

Saturday, November 24, 2012

Google Alert - pharmaceutical news

News2 new results for pharmaceutical news
 
Quebec's plan to nurse Montreal's battered pharmaceutical sector back to health
Globe and Mail
Starting from the best projects put forward by universities and research centres, it will develop promising molecules to a stage where pharmaceutical companies would acquire them, explains Mr. Walker, NéoMed's chief scientific officer. Unveiled ...
See all stories on this topic »

Globe and Mail
Why MAP Pharmaceutical Shares Popped
Motley Fool
What: Shares of development-stage drug company MAP Pharmaceutical (Nasdaq: MAPP ) jumped as high as 20% today, after its New Drug Application resubmission for Levadex was accepted by the FDA. So what: The FDA's ruling helps pave the way for ...
See all stories on this topic »


Tip: Use site restrict in your query to search within a site (site:nytimes.com or site:.edu). Learn more.

Delete this alert.
Create another alert.
Manage your alerts.

Friday, November 23, 2012

Google Alert - pharmaceutical news

News9 new results for pharmaceutical news
 
Union Cabinet of India approved the National Pharmaceutical Pricing Policy
Jagran Josh
National Pharmaceutical Pricing Policy The Union Cabinet of India on 22 November 2012 passed the National Pharmaceutical Pricing Policy (NPPA). As per the new pricing policy declared by the Union Government, 348 essential drugs would come under ...
See all stories on this topic »

Jagran Josh
64th Indian Pharmaceutical Congress to be held from Dec 7 to 9
pharmabiz.com
The 64th Indian Pharmaceutical Congress, 2012, being hosted by the Association of Pharmaceutical Teachers of India (APTI) will be held from December 7 to 9, 2012 at SRM University Campus, Chennai. The theme of the Congress is Vision 2020: Pharmacy ...
See all stories on this topic »
The pharmaceutical path to superworkers
Financial Times
Whatever your unique selling point, in the eyes of your employer it can probably be sharpened. And soon, that could be done through a performance-boosting drug or robotic enhancement. According to Human Enhancement and the Future of Work, a joint ...
See all stories on this topic »
Rexahn wins US patent for oncology-based compounds
Pharmaceutical Business Review
Rexahn wins US patent for oncology-based compounds. PBR Staff Writer Published 23 November 2012. Clinical stage pharmaceutical company Rexahn Pharmaceuticals has secured a US patent No. 8,314,100 for its Quinoxalinyl-piperazine compounds.
See all stories on this topic »
South Africa Pharmaceuticals Market Opportunities and Challenges Forecasts in ...
PR Web (press release)
Headline Expenditure Projections Pharmaceuticals: ZAR27.19bn (US$3.74bn) in 2011 to ZAR29.61bn (US$3.61bn) in 2012; +8.9% in local currency and -3.5% in US dollar terms. Healthcare: ZAR261.51bn (US$36.01bn) in 2011 to ZAR285.26bn ...
See all stories on this topic »
Indian government endorses plan to cap prices of 348 drugs
The Pharma Letter
India's Union Cabinet yesterday endorsed the Group of Ministers' (GoM) recommendations on the National Pharmaceutical Pricing Policy (NPPP), in move that will have ramification not only on the pharmaceutical industry but also on the interests of ...
See all stories on this topic »
Two Allentown men fired after brawl at pharmaceutical company, police say
The Express Times - LehighValleyLive.com
Two Allentown men were fired by a Northampton County pharmaceutical company following a fist fight at work, according to police reports. Nathaniel Medina, 25, and Ethan Martin, 37, were issued citations for harassment after a Nov. 13 fight at Piramal ...
See all stories on this topic »
Pharmaceutical merger okayed
Europolitics.info
The European Commission granted clearance, on 22 November, to the acquisition by Mid Europa Partners (MEP) of the UK of a 50% shareholding in Walmark, from seven Czech individuals. Walmark is active in the production and distribution in Poland of ...
See all stories on this topic »
"Joined-up" approach needed in UK to deliver life sciences strategy
The Pharma Letter
A report published yesterday by IMS Health - which shows the slow progress being made on the uptake of new medicines in the UK - has led the chief of the Association of the British Pharmaceutical Industry (ABPI) to call for a more joined up approach to ...
See all stories on this topic »


Tip: Use quotes ("like this") around a set of words in your query to match them exactly. Learn more.

Delete this alert.
Create another alert.
Manage your alerts.

Thursday, November 22, 2012

Google Alert - pharmaceutical news

News10 new results for pharmaceutical news
 
Govt clears drug pricing policy to lower cost of medicines
Hindu Business Line
The government today cleared the National Pharmaceutical Pricing Policy that will bring 348 essential drugs under price control, leading to reduction in prices. "The National Pharmaceutical Pricing policy has been approved by the Cabinet with an ...
See all stories on this topic »

Hindu Business Line
TEXT-S&P Rates CFR Pharmaceuticals SA 'BB+'; Outlook Stable
Reuters
Chilean pharmaceutical company CFR Pharmaceuticals S.A. (CFR) continues to grow through acquisitions in Latin America, especially in investment-grade countries. The company plans to use debt to finance its most recent acquisition in Colombia for about ...
See all stories on this topic »
Pharmaceutical sector under scrutiny
International Law Office
On August 6 2012 the Competition Authority was notified of the acquisition of sole control over Pharmexx GmbH (a German group with activities in several countries, including Portugal) by United Drug plc (part of an Irish group). Pharmexx is active in ...
See all stories on this topic »
Rexahn Pharmaceuticals Inc wins US patent for quinoxalinyl-piperazine ...
MENAFN.COM
Nov 22, 2012 (Menafn - M2 EQUITYBITES via COMTEX) --Pharmaceutical company Rexahn Pharmaceuticals Inc RNN revealed on Wednesday the receipt of a US patent titled '1-[6,7-substituted alkoxyquinoxalinyl) aminocarbonyl]-4-(hetero) arylpiperazine ...
See all stories on this topic »
Pacira Pharmaceuticals Q3 net loss widens
Equities.com
Nov 22, 2012 (Datamonitor via COMTEX) -- Pacira Pharmaceuticals, Inc., a specialty pharmaceutical company, has reported that net loss for the third quarter ended September 30, 2012 was $15.74 million, or $0.49 loss per share, compared to a net loss of ...
See all stories on this topic »
Sihuan Pharma inks pact with NeuroVive to develop two innovative CCV ...
pharmabiz.com
SihuanPharmaceutical Holdings Group Ltd., a leading pharmaceutical company with the largestcardio-cerebral vascular (CCV) drug franchise in China's prescription market, has entered into a collaboration agreement with NeuroVivePharmaceutical AB, ...
See all stories on this topic »
Cosmeceuticals: Bridging The Gap Between Cosmetics And Pharmaceuticals
Seeking Alpha
It can be safely said that people have been obsessing over beauty and youth since the beginning of time. Ancient civilizations and cultures had their own concoctions and herbal potions to ward off the ravages of aging. Then there were those mixtures ...
See all stories on this topic »
Fire Guts Dannex Drugs
Daily Guide
Fire on Wednesday afternoon gutted one of the warehouses of Dannex Ghana Limited, manufacturers and distributors of pharmaceutical products in North Industrial Area, Accra. The fire, which started around 12:10pm, destroyed a substantial amount of the ...
See all stories on this topic »

Daily Guide
Pharmaceutical imports from Switzerland
Europolitics.info
Switzerland was listed, on 22 November, as the first non-EU country with standards in the manufacture of active pharmaceutical ingredients equivalent to those of the EU. After a successful assessment, the European Commission concluded that the ...
See all stories on this topic »
Biocon chief views NPPA order on insulin pricing as discriminatory, favouring ...
pharmabiz.com
National Pharmaceutical Pricing Authority (NPPA)'s recent ruling with two ceiling prices, one for domestic product and other for imported version, has now stirred a hornet's nest. The country's domestic insulin major Biocon with its product Insugen ...
See all stories on this topic »


Tip: Use site restrict in your query to search within a site (site:nytimes.com or site:.edu). Learn more.

Delete this alert.
Create another alert.
Manage your alerts.

Bullets

Total Pageviews

Pages

Twitter Delicious Facebook Digg Stumbleupon Favorites More

 
Design by Free WordPress Themes | Bloggerized by Lasantha - Premium Blogger Themes | Web Hosting Bluehost